Phase 2 Acute Myeloid Leukemia, in Relapse Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

Acute Myeloid Leukemia, in Relapse

ARCE Therapeutics, Inc.49 enrolled3 locationsNCT06680752

Recruiting

Phase 2

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

Chronic Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more

St. Petersburg State Pavlov Medical University88 enrolled1 locationNCT06532084